- Home
- WOOF vs CRMD Comparison
WOOF vs CRMD Comparison
Compare WOOF & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOOF
- CRMD
- Stock Information
- Founded
- WOOF 1965
- CRMD 2006
- Country
- WOOF United States
- CRMD United States
- Employees
- WOOF N/A
- CRMD N/A
- Industry
- WOOF Other Specialty Stores
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- WOOF Consumer Discretionary
- CRMD Health Care
- Exchange
- WOOF Nasdaq
- CRMD Nasdaq
- Market Cap
- WOOF 937.4M
- CRMD 901.8M
- IPO Year
- WOOF 2021
- CRMD 2010
- Fundamental
- Price
- WOOF $3.46
- CRMD $13.69
- Analyst Decision
- WOOF Buy
- CRMD Strong Buy
- Analyst Count
- WOOF 8
- CRMD 7
- Target Price
- WOOF $3.75
- CRMD $16.83
- AVG Volume (30 Days)
- WOOF 2.6M
- CRMD 3.4M
- Earning Date
- WOOF 08-28-2025
- CRMD 08-07-2025
- Dividend Yield
- WOOF N/A
- CRMD N/A
- EPS Growth
- WOOF N/A
- CRMD N/A
- EPS
- WOOF N/A
- CRMD 0.79
- Revenue
- WOOF $6,080,721,000.00
- CRMD $121,484,498.00
- Revenue This Year
- WOOF $0.03
- CRMD $278.96
- Revenue Next Year
- WOOF $1.36
- CRMD $45.85
- P/E Ratio
- WOOF N/A
- CRMD $17.30
- Revenue Growth
- WOOF N/A
- CRMD 14970.29
- 52 Week Low
- WOOF $2.28
- CRMD $4.87
- 52 Week High
- WOOF $6.29
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- WOOF 55.49
- CRMD 65.34
- Support Level
- WOOF $3.25
- CRMD $12.80
- Resistance Level
- WOOF $3.60
- CRMD $13.56
- Average True Range (ATR)
- WOOF 0.16
- CRMD 0.86
- MACD
- WOOF 0.01
- CRMD 0.27
- Stochastic Oscillator
- WOOF 78.42
- CRMD 84.47
About WOOF Petco Health and Wellness Company Inc.
Petco Health and Wellness Co Inc is a pet specialty retailer focused on improving the lives of pets, pet parents, and its own partners with pet care centers in approximately 50 states, the District of Columbia and Puerto Rico. The Company also offers an expanded range of consumables, supplies, and services through its website and mobile app.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.